These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7973453)

  • 1. Kinetics of somatic mutation in lymph node germinal centres.
    Källberg E; Gray D; Leanderson T
    Scand J Immunol; 1994 Nov; 40(5):469-80. PubMed ID: 7973453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of somatic mutation activity in multiple V kappa genes involved in the response to 2-phenyl-5-oxazolone.
    Källberg E; Gray D; Leanderson T
    Int Immunol; 1993 Jun; 5(6):573-81. PubMed ID: 8347553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facultative role of germinal centers and T cells in the somatic diversification of IgVH genes.
    Miller C; Stedra J; Kelsoe G; Cerny J
    J Exp Med; 1995 Apr; 181(4):1319-31. PubMed ID: 7535332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of germinal centres in the immune response to oxazolone.
    Ziegner M; Berek C
    Adv Exp Med Biol; 1994; 355():201-5. PubMed ID: 7709823
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of somatic mutation in a kappa light chain transgene.
    Sharpe MJ; Neuberger M; Pannell R; Surani MA; Milstein C
    Eur J Immunol; 1990 Jun; 20(6):1379-85. PubMed ID: 2115000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of individual immunoglobulin lambda light chain genes amplified from single cells is inconsistent with variable region gene conversion in germinal-center B cell somatic mutation.
    Ford JE; McHeyzer-Williams MG; Lieber MR
    Eur J Immunol; 1994 Aug; 24(8):1816-22. PubMed ID: 8056040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation of the immune response in germinal centers.
    Berek C; Berger A; Apel M
    Cell; 1991 Dec; 67(6):1121-9. PubMed ID: 1760840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5' boundary of somatic hypermutation in a V kappa gene is in the leader intron.
    Rada C; González-Fernández A; Jarvis JM; Milstein C
    Eur J Immunol; 1994 Jun; 24(6):1453-7. PubMed ID: 8206104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of antibody diversity in single germinal centers: selective expansion of high-affinity variants.
    Ziegner M; Steinhauser G; Berek C
    Eur J Immunol; 1994 Oct; 24(10):2393-400. PubMed ID: 7925566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic hypermutation of Ig genes is affected differently by failures in apoptosis caused by disruption of Fas (lpr mutation) or by overexpression of Bcl-2.
    Mastache EF; Lindroth K; Fernández C; González-Fernández A
    Scand J Immunol; 2006 Jun; 63(6):420-9. PubMed ID: 16764695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human.
    Küppers R; Hajadi M; Plank L; Rajewsky K; Hansmann ML
    Eur J Immunol; 1996 Aug; 26(8):1794-800. PubMed ID: 8765023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutation of immunoglobulin V genes in vitro.
    Källberg E; Jainandunsing S; Gray D; Leanderson T
    Science; 1996 Mar; 271(5253):1285-9. PubMed ID: 8638111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Original and artificial antibodies.
    Gherardi E; Milstein C
    Nature; 1992 May; 357(6375):201-2. PubMed ID: 1589019
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutation and selection during the secondary response to 2-phenyloxazolone.
    Rada C; Gupta SK; Gherardi E; Milstein C
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5508-12. PubMed ID: 1905811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low antigen dose favours selection of somatic mutants with hallmarks of antibody affinity maturation.
    González-Fernández A; Milstein C
    Immunology; 1998 Feb; 93(2):149-53. PubMed ID: 9616362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity maturation leads to differential expression of multiple copies of a kappa light-chain transgene.
    Lozano F; Rada C; Jarvis JM; Milstein C
    Nature; 1993 May; 363(6426):271-3. PubMed ID: 8487865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular lymphoma immunoglobulin kappa light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains.
    Stamatopoulos K; Kosmas C; Papadaki T; Pouliou E; Belessi C; Afendaki S; Anagnostou D; Loukopoulos D
    Br J Haematol; 1997 Jan; 96(1):132-46. PubMed ID: 9012699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutations in antibodies expressed by germinal centre B cells early after primary immunization.
    Apel M; Berek C
    Int Immunol; 1990; 2(9):813-9. PubMed ID: 2279001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light chain germ-line genes and the immune response to 2-phenyloxazolone.
    Even J; Griffiths GM; Berek C; Milstein C
    EMBO J; 1985 Dec; 4(13A):3439-45. PubMed ID: 3937727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.